GoodRx on Wednesday launched a new platform designed to enable employers to lower the cost of high-impact brand medications, including GLP-1s, by applying targeted subsidies to discounted cash prices from drug manufacturers. GoodRx Employer Direct gives employers a scalable, cost-conscious way to improve affordability without adding plan complexity, a company news release said.
"Employers are under mounting pressure to do more with less as health care costs climb and employees shoulder greater out-of-pocket expenses," said Wendy Barnes, the company's president and CEO. "Employer Direct is built to meet that moment. It closes critical coverage gaps, expands access to high-impact therapies and delivers transparent, predictable pricing -- without layering on the complexity and opacity of the traditional rebate-driven system."
Employers can select high-impact brand medications, such as the popular weight-loss drug Wegovy, and directly subsidize the manufacturer-sponsored price available on GoodRx. This further lowers the employee's cost without adding the medication to the traditional insurance benefit. Employer contributions are applied seamlessly at the pharmacy counter, so employees automatically pay a reduced out-of-pocket amount.
GoodRx launched this model at the start of the year with its first employer partners, including Midwestern grocery chain Hy-Vee. The initial focus is on GLP-1 medications, a category that has seen significant demand but variable insurance coverage.
"As an employer, we're constantly looking for ways to make our health benefits more impactful and easier to use," Vice President Angie Nelson said. "GoodRx Employer Direct gives us the flexibility to support access to high-impact medications while keeping our overall plan structure intact. It's a practical way to invest in the therapies our employees need most and ensure they see real savings when they fill their prescriptions."
Employers can improve access to high-cost brand medications by offering tailored versions of GoodRx's condition-specific telemedicine solutions, including for weight loss. These employer-aligned programs integrate clinical care and access to FDA-approved therapies with transparent pricing and coordinated pharmacy fulfillment. They are delivered through a single, streamlined experience that fits within an employer's broader benefits strategy.
By combining established pharmaceutical partnerships that enable low self-pay pricing with its nationwide pharmacy network and broad consumer reach, GoodRx is positioned to deliver affordable, transparent access solutions directly within employer health plans. Employer Direct formalizes this integrated model into a unified enterprise offering in an emerging market, giving employers a modern alternative to traditional, opaque insurance models.
"By leveraging the pricing and access infrastructure we've built and our deep relationships across the health care ecosystem," Barnes said. "We're bringing a fundamentally smarter, more sustainable model to employers and the people they serve."
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.